Gilead Sciences
GILD
#105
Rank
S$224.05 B
Marketcap
S$180.57
Share price
1.72%
Change (1 day)
39.73%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): S$8.54

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is S$8.29. In 2024 the company made an earnings per share (EPS) of S$0.48 a decrease over its 2023 EPS that were of S$5.79.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$8.541665.95%
2024S$0.48-91.65%
2023S$5.7923.98%
2022S$4.67-25.86%
2021S$6.304850%
2020S$0.13-97.64%
2019S$5.390.9%
2018S$5.3518.71%
2017S$4.50-64.88%
2016S$12.82-18.45%
2015S$15.7255.28%
2014S$10.13296.02%
2013S$2.5617.89%
2012S$2.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$13.28 60.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$2.19-73.62%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$1.72-79.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$26.10 214.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$16.58 99.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$13.98 68.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$5.69-31.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$18.23 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.66 16.47%๐Ÿ‡บ๐Ÿ‡ธ USA